Zevra Therapeutics Stock Zoomed: Why the 21% Jump Happened
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Identify what to focus on for retirement in your 40s. Stay proactive in securing your financial well-being as you age.
22,435 articlesZevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Among the market’s biggest names, only a few of the so-called magnficent seven look like buys today. This piece digs ...
DLocal faces a pivotal year as Q1 2026 results shape the path to 2026 earnings. This guide breaks down the key metric...
As June approaches, Netflix stock may be on the radar for investors seeking a rebound. This article highlights three ...
Micron ralled dramatically in May as memory chips rode AI and data-center demand. This deep dive explains what fueled...
Roblox faces a tough year in the market, but a rebound isn’t off the table. This guide breaks down the business, risk...
A new player in the chip foundry race is signaling aggressive pricing. If a potential rival wants undercut, investors...
Vistance (VISN) reports for 2025 show meaningful progress in revenue and margins, but the real story is how the compa...
A mid-February 2026 SEC filing shows Bank Hapoalim taking a new position in the FTCS ETF, worth about $14.7 million. ...
The crypto market has cooled from its peaks, but two names consistently draw attention: Ethereum and Solana. This gui...
Microsoft stock is moving higher in a volatile market, defying a tech sell-off. This article breaks down the drivers ...
Investors are asking if sofi stock finally bottomed? This guide breaks down the signals, what the data actually shows...